Folinic Acid vs Methylfolate vs Folic Acid: Matching the Form to the Indication

Three folate forms appear on supplement and prescription labels: folic acid (synthetic), L-methylfolate (5-MTHF, the active form), and folinic acid (5-formyltetrahydrofolate, also called leucovorin in pharmacy). Each occupies a specific niche, but online wellness culture tends to recommend whichever is most expensive. Matching the form to the indication produces better outcomes at a fraction of the cost.

The folate cycle in two sentences

All three forms ultimately enter the same metabolic pool, where 5,10-methylenetetrahydrofolate donates methyl groups for DNA synthesis (thymidylate synthesis, purine synthesis) and 5-methyltetrahydrofolate donates a methyl group to homocysteine to form methionine via methionine synthase. The differences between forms are in absorption, the enzymes required to enter the pool, and which downstream pathway is preferentially fed.

Folic acid: the public-health workhorse

Folic acid is a synthetic, fully oxidized form that must be reduced by dihydrofolate reductase (DHFR) twice to become tetrahydrofolate. At doses up to about 200-400 mcg/day, this conversion is efficient. At higher doses (above ~1,000 mcg), unmetabolized folic acid (UMFA) appears in plasma, the long-term implications of which remain debated. Folic acid is the form used in nearly all national fortification programs (cereals in the U.S. since 1998, mandatory in most countries) and is the form proven by RCT to reduce neural tube defects. The Hibbard, MRC Vitamin Study, and Czeizel landmark trials used folic acid, not methylfolate [1].

L-methylfolate (5-MTHF): the active form

L-methylfolate is the form circulating in plasma and the form that crosses the blood-brain barrier. It is preferred when DHFR activity is reduced (methotrexate users, some genetic variants), when reducing UMFA exposure is desired, or in cerebral folate deficiency. The MTHFR C677T and A1298C polymorphisms produce thermolabile enzyme variants that modestly reduce 5,10-methylene-THF conversion to 5-MTHF; homozygous C677T (TT) individuals have lower plasma folate at the same dietary intake. Whether this matters clinically for routine prenatal supplementation is debated — most authorities continue to recommend standard folic acid 400-800 mcg/day for periconceptional use regardless of genotype, because the supplementation doses easily saturate the pathway [2].

Folinic acid (leucovorin, 5-formyl-THF)

Folinic acid enters the folate cycle downstream of DHFR, making it the preferred rescue agent during methotrexate therapy (preventing megaloblastic anemia and mucositis while preserving methotrexate's anti-folate effect on cancer cells via leucovorin protocol). It is also the form used in cerebral folate deficiency due to folate receptor autoantibodies, where it can cross the blood-brain barrier more efficiently than folic acid in this specific context [3]. Folinic acid has a small literature in pediatric autism trials with folate receptor autoantibodies — interesting but not yet practice-changing.

Pregnancy: which form to actually use

For periconceptional and pregnancy supplementation, folic acid 400-800 mcg/day starting at least one month before conception remains the global standard. ACOG, USPSTF, WHO, and NICE all recommend folic acid, not methylfolate, for primary prevention. For women with a prior NTD-affected pregnancy, the dose is 4,000 mcg/day. The argument that MTHFR variants require methylfolate substitution is not supported by current authority guidelines; the standard folic acid dose is sufficient even in homozygous variants [4].

When to choose each form

For routine prenatal use and population-level deficiency prevention, folic acid is the right answer. For people on methotrexate or with suspected cerebral folate deficiency, folinic acid is the right answer. For people with documented elevated UMFA, on certain antiseizure medications that inhibit DHFR, or with depression and very high MTHFR variant burden where adjunctive treatment is being tried, L-methylfolate has a niche [5]. For everyone else, the premium for methylfolate buys marketing more than biology.